A 14-year-old Aboriginal girl from a remote community has a history of acute rheumatic fever with mild mitral regurgitation. She has been on secondary prophylaxis for 2 years with intramuscular benzathine benzylpenicillin G every 28 days. She has recently had a recurrence of rheumatic fever despite good adherence. What is the most appropriate adjustment to her prophylactic antibiotic regimen?